Evidence map›Paper›PMID 39436892›Full record

ArticlePloS one2024

Development and validation of a cardiovascular risk prediction model for Sri Lankans using machine learning.

Chamila Mettananda, Isuru Sanjeewa, Tinul Benthota Arachchi, Avishka Wijesooriya, Chiranjaya Chandrasena, Tolani Weerasinghe, Maheeka Solangaarachchige, Achila Ranasinghe, Isuru Elpitiya, Rashmi Sammandapperuma and 8 more

Erratum issuedAbstract readValidation Study
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Chamila MettanandaDepartment of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.ORCID 0000-0002-3328-1553
Isuru SanjeewaFaculty of Computing, Sri Lanka Institute of Information Technology, Malabe, Sri Lanka.
Tinul Benthota ArachchiFaculty of Computing, Sri Lanka Institute of Information Technology, Malabe, Sri Lanka.
Avishka WijesooriyaFaculty of Computing, Sri Lanka Institute of Information Technology, Malabe, Sri Lanka.
Chiranjaya ChandrasenaFaculty of Computing, Sri Lanka Institute of Information Technology, Malabe, Sri Lanka.
Tolani WeerasingheFaculty of Computing, Sri Lanka Institute of Information Technology, Malabe, Sri Lanka.
Maheeka SolangaarachchigeComputer Centre, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Achila RanasingheDepartment of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Isuru ElpitiyaDepartment of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Rashmi SammandapperumaDepartment of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Sujeewani KurukulasooriyaDepartment of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.ORCID 0000-0001-8765-9366
Udaya RanawakaDepartment of Medicine, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.ORCID 0000-0002-4050-062X
Arunasalam PathmeswaranDepartment of Public Health, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Anuradhini KasturiratneDepartment of Public Health, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Nei KatoNational Centre for Global Health and Medicine, Toyama, Shinjuku-ku, Tokyo, Japan.
Rajitha WickramasingheDepartment of Public Health, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Prasanna HaddelaFaculty of Computing, Sri Lanka Institute of Information Technology, Malabe, Sri Lanka.
Janaka de SilvaDepartment of Medicine, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION AND

objectivesSri Lankans do not have a specific cardiovascular (CV) risk prediction model and therefore, World Health Organization(WHO) risk charts developed for the Southeast Asia Region are being used. We aimed to develop a CV risk prediction model specific for Sri Lankans using machine learning (ML) of data of a population-based, randomly selected cohort of Sri Lankans followed up for 10 years and to validate it in an external cohort. MATERIAL AND

methodsThe cohort consisted of 2596 individuals between 40-65 years of age in 2007, who were followed up for 10 years. Of them, 179 developed hard CV diseases (CVD) by 2017. We developed three CV risk prediction models named model 1, 2 and 3 using ML. We compared predictive performances between models and the WHO risk charts using receiver operating characteristic curves (ROC). The most predictive and practical model for use in primary care, model 3 was named "SLCVD score" which used age, sex, smoking status, systolic blood pressure, history of diabetes, and total cholesterol level in the calculation. We developed an online platform to calculate the SLCVD score. Predictions of SLCVD score were validated in an external hospital-based cohort.

resultsModel 1, 2, SLCVD score and the WHO risk charts predicted 173, 162, 169 and 10 of 179 observed events and the area under the ROC (AUC) were 0.98, 0.98, 0.98 and 0.52 respectively. During external validation, the SLCVD score and WHO risk charts predicted 56 and 18 respectively of 119 total events and AUCs were 0.64 and 0.54 respectively.

conclusionsSLCVD score is the first and only CV risk prediction model specific for Sri Lankans. It predicts the 10-year risk of developing a hard CVD in Sri Lankans. SLCVD score was more effective in predicting Sri Lankans at high CV risk than WHO risk charts.

Indexed as

Cardiovascular DiseasesMachine LearningAdultAgedCohort StudiesFemaleHeart Disease Risk FactorsHumansMaleMiddle AgedRisk AssessmentRisk FactorsROC CurveSri Lanka

Identifiers

PMID39436892
PMCPMC11495576

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.